| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Christopher J Twomey is Director at BNGO and has filed Form 4s across 2 companies. From February 2018 to October 2026, the filings on record show 2 open-market purchases and 11 sales. Christopher J Twomey's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $509K at current prices.
Historically, Christopher J Twomey's trades have earned a middling insider score of 59/100 across 7 rated trades. Over a 12-month horizon, 71.4% of those trades were profitable, with an average 12-month return of +28.3%.
The biggest single holding is TNDM (~$431K) as Director. Net of sales, the TNDM filings show accumulation of 20,975 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 30, 2020 | TNDM Tandem Diabetes Care Inc | Director | Sell | 4,308 | $80.00 | $344,640.00 | -14.7% | |
| Aug 23, 2018 | BNGO Bionano Genomics, Inc. | Director | Buy | 10,000 | $6.13 | $61,250.00 | New | |
| Feb 9, 2018 | TNDM Tandem Diabetes Care Inc | Director | Buy | 75,000 | $2.00 | $150,000.00 | -155.5% |